Anna Gutkin

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

Daniel Rosenblum, Anna Gutkin, Ranit Kedmi et al. · Science Advances · 2020 · 584 citations · Full text

Life Sciences, Biotechnology, Oncology +17

Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells

Anna Gutkin, Orit Uziel, Einat Beery et al. · Oncotarget · 2016 · 116 citations · Full text

Medicine, Cell Biology, Oncology +17

Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker

Hadar Goldvaser, Anna Gutkin, Einat Beery et al. · British Journal of Cancer · 2017 · 54 citations · Full text

Medicine, Cancer Biology, Oncology +16

Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles

Liyona Kampel, Meir Goldsmith, Srinivas Ramishetti et al. · Journal of Controlled Release · 2021 · 48 citations

Pharmacy, Cancer Biology, Oncology +16

Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma

Maya Shumer-Elbaz, Nitay Ad‐El, Yulia Chulanova et al. · Journal of Controlled Release · 2025 · 18 citations · Full text

Pharmacy, Bioengineering, Biomedical Engineering +17